RA

Rosalind Advisors Portfolio holdings

AUM $207M
1-Year Est. Return 62.29%
This Quarter Est. Return
1 Year Est. Return
+62.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$205M
AUM Growth
+$19.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$11.5M
2
+$10.5M
3
+$8.02M
4
REPL icon
Replimune Group
REPL
+$5.75M
5
NUVB icon
Nuvation Bio
NUVB
+$4.31M

Top Sells

1
+$10.6M
2
+$5.69M
3
+$3.34M
4
VRNA
Verona Pharma
VRNA
+$3.17M
5
TRVI icon
Trevi Therapeutics
TRVI
+$2.83M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COGT icon
26
Cogent Biosciences
COGT
$2.29B
$1.49M 0.72%
+248,285
TLPH icon
27
Talphera
TLPH
$48.8M
$992K 0.48%
2,003,939
+1,390,000
KPRX icon
28
Kiora Pharmaceuticals
KPRX
$9.3M
$753K 0.37%
250,059
-496
KURA icon
29
Kura Oncology
KURA
$854M
$660K 0.32%
+100,000
ACOG
30
Alpha Cognition
ACOG
$142M
$530K 0.26%
104,836
-147,917
BFRI icon
31
Biofrontera
BFRI
$10.2M
$516K 0.25%
644,393
-167,525
BMEA icon
32
Biomea Fusion
BMEA
$107M
– –
0
CADL icon
33
Candel Therapeutics
CADL
$293M
– –
0
CRMD icon
34
CorMedix
CRMD
$795M
– –
0
EWTX icon
35
Edgewise Therapeutics
EWTX
$1.59B
– –
0
LXRX icon
36
Lexicon Pharmaceuticals
LXRX
$516M
– –
0
NMRA icon
37
Neumora Therapeutics
NMRA
$280M
– –
0
OEF icon
38
iShares S&P 100 ETF
OEF
$26.9B
– –
0
OWLT icon
39
Owlet
OWLT
$148M
– –
-49,441
QQQ icon
40
Invesco QQQ Trust
QQQ
$384B
– –
0
RLMD icon
41
Relmada Therapeutics
RLMD
$66.7M
– –
-100,000
SAVA icon
42
Cassava Sciences
SAVA
$208M
– –
-417,400
XNTK icon
43
SPDR NYSE Technology ETF
XNTK
$1.45B
– –
0
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
– –
-3,050,000
1
2